Discusses ABS-201 Program and Clinical Approach for Androgenetic Alopecia December 11, 2025 10:00 AM ESTCompany ...

Artificial intelligence is rapidly transforming clinical medicine, with AI-powered tools increasingly being used for ...

ORLANDO -- A gene therapy that could transform CAR T-cell treatment achieved rapid and potentially durable measurable ...

Microphysiological systems help address the shortcomings of animal models for mAb development, and CN Bio is taking an active ...

HANGZHOU, China and SHANGHAI and BOSTON, Dec. 10, 2025 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals") ...

Insilico Medicine has developed a new class of small molecule inhibitors targeting diacylglycerol kinase alpha (DGKα) designed to restore T cell ...

Bruker's Acquifer Imaging Machine (IM) is a fully automated widefield microscope with both brightfield and fluorescence ...

The World Health Organisation’s (WHO) establishment of its first-ever Civil Society Task Force on Antimicrobial Resistance (AMR) in 2025 marks a transformative moment in the global fight against ...

Introduction Prescribing high-dose antipsychotics is typically reserved for individuals with treatment-resistant severe ...

AN ENLIGHTENING session, entitled ‘Emerging therapeutic frontiers in cardiology: what does the future hold?’, delivered at ...

Study met its primary endpoint demonstrating that GRI-0621 was well tolerated over 12 weeks of treatment, with no drug-related severe or serious ...

US AI-focused start-up Formation Bio has entered a deal with Lynk Pharmaceuticals for worldwide rights, excluding Greater ...